|
|
|
|
|
Session 36
Poster Presentations Accessory Genes Session Day and Time: Tuesday 1:30 - 3:30 pm Room: Hall D |
Background: Despite continuing advances in our understanding of
AIDS pathogenesis, the mechanism of CD4+ T-cell depletion in HIV-1 infected
individuals remains unknown. The Vpr accessory protein of HIV-1 has been
reported to cause cell death, as well as enhance transcriptional activity of
the proviral long terminal repeat (LTR), target the pre-integration complex to
the nucleus, and arrest cells in the G2/M phase. Although several Vpr functions
have been associated with cell killing, it is not clear which, if any, of the
known Vpr activities causes death. We investigated the molecular mechanism by
which Vpr contributes to direct viral cytopathicity in CD4+ T-cells
in the context of HIV-1 infection as well as in its virion-associated form.
Methods: Vpr cytopathicity resulting from either HIV-1
infection with NL4-3 or virion-associated Vpr was measured by flow cytometry
and compared amongst wild-type Vpr and cell cycle arrest mutants of Vpr. Vpr-induced
cell cycle blockade was detected by propidium iodide staining for DNA content.
T-cell killing by virion-delivered Vpr was assessed for apoptosis by Annexin V
binding.
Results: C-terminal truncation of Vpr was found to completely
abrogate virion-associated Vpr cell death in Jurkat T-cells. Furthermore,
virions containing these Vpr mutants were unable to induce cell cycle arrest in
G2/M, as measured by hyperdiploid DNA content, suggesting that virion Vpr
cytotoxicity is associated with the arrest-inducing activity of Vpr. In
addition, Vpr-mediated killing does not appear apoptotic, as cells dying from
virion-associated Vpr did not flux phosphatidylserine. The cytopathic role of
the C-terminus of Vpr was further supported by chronic infection of T-cells
infected with NL4-3 containing Vpr C-terminal deletions without cytopathic
manifestations characteristic of infection with wild-type HIV-1.
Conclusions: Vpr was found to exert a cytopathic effect on T-cells
when delivered into cells by HIV-1 virions and when expressed during HIV-1
infection in vitro. We have mapped a cytopathic determinant of Vpr to the
C-terminus, which is also associated with mediating the G2/M cell cycle arrest.
Further understanding of the mechanism of Vpr toxicity may provide valuable
insight for strategies to prevent CD4+ T-cell loss by viral cytopathicity.